Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

WellCare makes CVS Health its pharmacy benefit manager

Health insurer WellCare Health Plans said it would change its pharmacy benefit manager to CVS Health Corp from UnitedHealth Corp’s Optum Rx, effective Jan. 1. About 3.8 million WellCare members enrolled under its Medicaid, Medicare and prescription drug plans will be able to access CVS’ pharmacy network, WellCare said on Thursday. Pharmacy benefit managers administer […]

Read More »

Endo International Kills Deals with VIVUS and Acerus

Endo International plc (ENDP), via its Auxilium Pharmaceuticals (AUXL) and Endo Ventures Limited subsidiaries, announced today that it has ended commercialization deals with VIVUS, Inc. (VVUS) and with Acerus Pharmaceuticals Corporation (TRLPF). On Jan. 29, 2015, Dublin-based Endo International plc completed the acquisition of Auxilium Pharmaceuticals in a deal worth $2.6 billion. Endo is a […]

Read More »

Eating Potatoes On A Regular Basis May Up Risk Of T2DM, Study

Greater potato consumption is associated with increased risk of type 2 diabetes (T2D), according to a study published online Dec. 17 in Diabetes Care. Isao Muraki, M.D., Ph.D., from Osaka Center for Cancer and Cardiovascular Disease Prevention in Japan, and colleagues assessed data from three cohorts to examine the correlation between potato consumption and T2D. […]

Read More »

Early-Life Exercise Alters Gut Microbes, Promotes Healthy Brain And Metabolism, University of Colorado Study

Early-Life Exercise Alters Gut Microbes, Promotes Healthy Brain And Metabolism The human gut harbors a teeming menagerie of over 100 trillion microorganisms, and researchers at the University of Colorado Boulder have discovered that exercising early in life can alter that microbial community for the better, promoting healthier brain and metabolic activity over the course of […]

Read More »

India’s Cadila gets FDA warning for violating standards at two plants

India’s Cadila Healthcare Ltd said it received a warning from U.S. health regulators for violating manufacturing standards at two production sites in India, sending its shares down 17 percent to its biggest single-day percentage fall. The letter from the U.S. Food and Drug Administration cites issues at Cadila’s plants in the western state of Gujarat: […]

Read More »

Researchers describe controversial study of surgeon training

(Reuters Health) – Whether surgical trainees should be able to work long shifts is a matter of fierce debate, and the methods of a controversial study aimed at answering that question were outlined Wednesday in a top surgical journal. The results won’t be available until February. In the meantime, critics of the study say it […]

Read More »

More U.S. women using unapproved menopause hormones

(Reuters Health) – A growing number of U.S. women are filling prescriptions for unregulated hormones to ease menopause symptoms such as hot flashes and night sweats, a recent study suggests. Researchers focused on what’s known as compounded hormone therapy – prescriptions that are custom-blended by pharmacists instead of factory-made by drug companies and approved for […]

Read More »

Boston Scientific Engineer to Be Sentenced Today for Trade Secret Theft

Aaron Khieu, a former engineer with Boston Scientific Corp. (BSX) is expected to be sentenced today for the theft of intellectual property and trade secrets. In April, Khieu pleaded guilty in federal court to one felony count of stealing a trade secret. A federal grand jury had indicted him in September 2014 of 14 counts […]

Read More »

Novartis AG Finalizes Suffern, NY Plant Closure, Lays Off Remaining 61 Workers

December 30, 2015By Mark Terry, Breaking News Staff   Switzerland-based Novartis (NVS) announced that it is continuing with its plans to sell more than 160 acres around its Suffern, NY facilities. Novartis has been making fairly regular job cuts as the company restructures. On Jan. 19, 2015 it announced it was closing a manufacturing […]

Read More »

Acerus Announces Termination of NATESTO Agreement with Endo

Acerus Announces Termination of NATESTO™ Agreement with Endo TORONTO–(BUSINESS WIRE)– Acerus Pharmaceuticals Corporation (ASP.TO) today announced that the agreement with Endo Ventures Bermuda Limited (an affiliate of Endo International plc) relating to the commercialization of NATESTO™ in the United States and Mexico will be terminated, effective June 30, 2016. Under the terms of the agreement […]

Read More »

DuPont to Lay Off 1,700 Ahead of Merger With Dow Chemical

WILMINGTON, Del. – DuPont (DD) will slash about 28 percent of its Delaware workforce when it delivers 1,700 pink slips to employees in the early part of 2016 ahead of a merger with Dow Chemical, the Washington Post reported this morning. While unwelcome news for many, the layoffs were not unexpected. In early December, the […]

Read More »

Collegium Delays Launch of OxyContin Variation Xtampza

December 30, 2015By Mark Terry, Breaking News Staff   Canton, Mass.-based Collegium Pharmaceutical, Inc. (COLL), announced yesterday that it has delayed the launch of its pain medication Xtampza because of a patent lawsuit filed by Purdue Pharma. On Nov. 9, the U.S. Food and Drug Administration gave Xtampza ER (oxycodone) extended-release capsules tentative approval […]

Read More »

Martin Shkreli’s Former Drugmaker KaloBios Files for Bankruptcy

SAN FRANCISCO – Only months after what appeared to be a turnaround for struggling KaloBios Pharmaceuticals (KBIO), the cancer-making drug company has filed for Chapter 11 bankruptcy following the arrest of Martin Shkreli, its most recent chief executive officer and one of its largest shareholders. On Tuesday, the company filed for bankruptcy protection in U.S. […]

Read More »

Allergies may boost chances of anxiety or depression symptoms

(Reuters Health) – Kids who have allergies at an early age are more likely than others to also have problems with anxiety and depression, according to a new study. As the number of allergies increase, so do internalizing behavior scores, the researchers found. Internalizing behaviors include disorders, like anxiety or depression, that develop when people […]

Read More »

Should frail or demented patients have defibrillators implanted?

(Reuters Health) – Frailty and brain health should be taken into account when determining whether patients should have a defibrillator implanted in their chest, suggests a new study. More than 20 percent of patients with frailty or dementia died within a year of getting defibrillators, which means they likely didn’t benefit from the devices, researchers […]

Read More »

Type 2 diabetes increases dementia risk

(Reuters Health) – People with type 2 diabetes are at higher risk for dementia in general. And for one form, called vascular dementia, diabetes brings more risk to women than men, according to a new review. The most common cause of dementia is Alzheimer’s disease, which is non-vascular, said senior author Rachel R. Huxley of […]

Read More »

Asthma rate stops climbing in some U.S. kids

(Reuters Health) – Childhood asthma rates appear to have stopped rising among many U.S. groups, but not among the poorest kids or children aged 10 and older, a study suggests. Overall, asthma prevalence among kids under 18 had been rising for decades, until it peaked at 9.7% in 2009. Then it held steady until 2013, […]

Read More »

Many continue to receive opioid prescriptions after overdose

(Reuters Health) – Almost all people who overdose on prescription opioids continue to receive prescriptions for these painkillers, according to a new study.   “We found the results both surprising and concerning,” said lead author Dr. Marc R. Larochelle of Boston Medical Center. “While this study wasn’t designed to answer why, one possibility is that […]

Read More »

Anavex Shares Plummet After Company Discloses SEC Investigation and Subpoena

December 29, 2015By Alex Keown, Breaking News Staff   NEW YORK – Shares of Anavex Life Sciences (AVXL) are down more than 15 percent after the company revealed in a 10-K filing it received a subpoena from the U.S. Securities and Exchange Commission regarding “unusual activity” in the market over company shares. Anavex said […]

Read More »

Mylan Launches Generic Zyvox Tablets

HERTFORDSHIRE, England and PITTSBURGH, Dec. 29, 2015 /PRNewswire/ — Mylan N.V. (NASDAQ, TASE: MYL) today announced the U.S. launch of Linezolid Tablets, 600 mg, which is the generic version of Pfizer’s Zyvox® Tablets. Mylan received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for this product, which […]

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

August 2018 Focus: Top 200 Meds, Year After Launch, VR/AR and more!


Ad Right Bottom